Down regulation of miR-143 promotes radiation - Induced thymic lymphoma by targeting B7H1.

[1]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[2]  N. Bilous,et al.  The distribution of TP53 gene polymorphisms in chronic lymphocytic leukemia patients, sufferers of Chornobyl nuclear power plant accident. , 2016, Experimental oncology.

[3]  Guoqiang Chen,et al.  CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling , 2016, Journal of Hematology & Oncology.

[4]  Gregory J. Goodall,et al.  A network-biology perspective of microRNA function and dysfunction in cancer , 2016, Nature Reviews Genetics.

[5]  Lanjuan Li,et al.  MicroRNA-674-5p/5-LO axis involved in autoimmune reaction of Concanavalin A-induced acute mouse liver injury. , 2016, Toxicology letters.

[6]  G. Netto.  Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma , 2016, The Lancet.

[7]  E. Smit,et al.  PD-L1 in non-small-cell lung cancer: the third target for immunotherapy , 2016, The Lancet.

[8]  Q. Fu,et al.  miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR–p-PI3K/AKT-c-JUN , 2016, Nature Communications.

[9]  Mechthild Krause,et al.  Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.

[10]  Qizhan Liu,et al.  The IL-6/STAT3 pathway via miR-21 is involved in the neoplastic and metastatic properties of arsenite-transformed human keratinocytes. , 2015, Toxicology letters.

[11]  Kevin J. Harrington,et al.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.

[12]  William H. Bisson,et al.  Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis? , 2015, Carcinogenesis.

[13]  Mingfeng Zhang,et al.  B7H1/CD80 Interaction Augments PD-1–Dependent T Cell Apoptosis and Ameliorates Graft-versus-Host Disease , 2015, The Journal of Immunology.

[14]  Thomas M. Keane,et al.  The mutational landscapes of genetic and chemical models of Kras-driven lung cancer , 2014, Nature.

[15]  Pei Zhang,et al.  Down Regulation of miR200c Promotes Radiation‐Induced Thymic Lymphoma by Targeting BMI1 , 2014, Journal of cellular biochemistry.

[16]  J. Lin,et al.  A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance , 2013, Cell Death and Disease.

[17]  Jing Lin,et al.  miR‐200c enhances radiosensitivity of human breast cancer cells , 2013, Journal of cellular biochemistry.

[18]  Y. Akao,et al.  Downregulation of anti-oncomirs miR-143/145 cluster occurs before APC gene aberration in the development of colorectal tumors , 2013, Medical Molecular Morphology.

[19]  Margaret S. Ebert,et al.  Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.

[20]  J. Mendell,et al.  MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.

[21]  Jing Lin,et al.  MiR-21 plays an Important Role in Radiation Induced Carcinogenesis in BALB/c Mice by Directly Targeting the Tumor Suppressor Gene Big-h3 , 2011, International journal of biological sciences.

[22]  Wei Wu,et al.  MiR-34a in Age and Tissue Related Radio-Sensitivity and Serum miR-34a as a Novel Indicator of Radiation Injury , 2011, International journal of biological sciences.

[23]  Li Lin,et al.  Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. , 2011, Cancer cell.

[24]  Y. Akao,et al.  Role of anti-oncomirs miR-143 and -145 in human colorectal tumors , 2010, Cancer Gene Therapy.

[25]  Robert L. Judson,et al.  Opposing microRNA families regulate self-renewal in mouse embryonic stem cells , 2010, Nature.

[26]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[27]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[28]  Y. Akao,et al.  Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers , 2009, Oncology.

[29]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[30]  S. Hammond,et al.  HMGA2, MicroRNAs, and Stem Cell Aging , 2008, Cell.

[31]  D Williams,et al.  Radiation carcinogenesis: lessons from Chernobyl , 2008, Oncogene.

[32]  K. Nakachi,et al.  Sixty years of follow-up of Hiroshima and Nagasaki survivors: current progress in molecular epidemiology studies. , 2008, Mutation research.

[33]  J. Fernández-Piqueras,et al.  Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to γ-radiation-induced thymic lymphoma , 2006, Oncogene.

[34]  G. Coukos,et al.  Radiotherapy combination opportunities leveraging immunity for the next oncology practice , 2017, CA: a cancer journal for clinicians.

[35]  J. Cui,et al.  Hydrogen therapy may be an effective and specific novel treatment for acute radiation syndrome. , 2010, Medical hypotheses.

[36]  K. Mishra,et al.  Radiation-induced incidence of thymic lymphoma in mice and its prevention by antioxidants. , 2007, Journal of Environmental Pathology And Toxicology.